Skip to main content
SpringerLink
Log in

Mood disorders and serotonin transporter density in ecstasy users—the influence of long-term abstention, dose, and gender

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) on the serotonin (5-HT) system have been described in animals and humans, but little is known about long-term effects of ecstasy use on mood.

Objectives

To investigate short-term and long-term effects of ecstasy use on mood and its association with 5-HT neurotoxicity, dose, and gender in humans.

Methods

Fifteen moderate ecstasy users, 23 heavy ecstasy users, 16 former heavy ecstasy users and 15 drug-using, but ecstasy-naive controls were included. Mood was assessed using the Composite International Diagnostic Interview (CIDI) and the Beck Depression Inventory (BDI). Outcomes were correlated with 5-HT transporter (SERT) density, assessed with [123I]β-CIT single photon emission computed tomography (SPECT).

Results

The prevalence of mood disorders assessed by CIDI did not differ between all groups. The overall test for differences in BDI scores between groups was near significance (P=0.056), with BDI scores higher in former heavy ecstasy users than in ecstasy-naive controls (P=0.045). BDI scores were correlated with the total number of ecstasy tablets used (r=0.310; P=0.021). No associations between CIDI or BDI outcomes and SERT density or gender were observed.

Conclusions

These results suggest that ecstasy use is not associated with clinical depression (CIDI). However, the number of ecstasy tablets taken lifetime was associated with higher BDI scores for depressive mood, and this relationship seemed to persist after ecstasy use had stopped. We did not find that depressed mood in ecstasy users was associated with decrease in SERT density. Prospective studies are needed to establish the causal relationship between ecstasy use and depressed mood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorder, 4th edn. American Psychiatric Press, Washington D.C.

  • Beck AT, Steer RA (1984) Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40:1365–1367

    CAS  PubMed  Google Scholar 

  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    CAS  Google Scholar 

  • Bijl RV, Ravelli A, van Zessen G (1998) Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 33:587–595

    Article  CAS  PubMed  Google Scholar 

  • Bouman TK, Luteijn F, Albersnagel FA, Van der Ploeg FAE (1985) Enige ervaringen met de Beck Depression Inventory (BDI). Gedrag 13:13–24

    Google Scholar 

  • Cami J, Farre M, Mas M, Roset PN, Poudevida S, Mas A, San L, de la Torre R (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (“ecstasy”): psychomotor performance and subjective effects. J Clin Psychopharmacol 20:455–466

    Article  CAS  PubMed  Google Scholar 

  • Curran HV, Travill RA (1997) Mood and cognitive effects of ± 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”): week-end “high” followed by mid-week low. Addiction 92:821–831

    Article  CAS  PubMed  Google Scholar 

  • Dahlström M, Ahonen A, Ebeling H, Torniainen P, Heikkilä J, Moilanen I (2000) Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents. Mol Psychiatry 5:514–522

    Article  PubMed  Google Scholar 

  • Gamma A, Frei E, Lehmann D, Pascual-Marqui RD, Hell D, Vollenweider FX (2000) Mood state and brain electric activity in ecstasy users. Neuroreport 11:157–162

    CAS  PubMed  Google Scholar 

  • Gamma A, Buck A, Berthold T, Vollenweider FX (2001) No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2 15O]-positron emission tomography study. J Clin Psychopharmacol 21:66–71

    Article  CAS  PubMed  Google Scholar 

  • Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R, Caccavari R, Delsignore R (1998) Serotonergic function after (±)3,4-methylene-dioxymethamphetamine (“ecstasy”) in humans. Int Clin Psychopharmacol 13:1–9

    CAS  PubMed  Google Scholar 

  • Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E, Marzocchi GF, Delsignore R, Brambilla F (2000) Long-lasting effects of (±)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Biol Psychiatry 47:127–136

    CAS  PubMed  Google Scholar 

  • Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719–725

    CAS  PubMed  Google Scholar 

  • Haddad PM, Strickland P, Anderson I, Deakin JF, Dursun SM (2002) Effects of MDMA (ecstasy) use and abstention on serotonin neurons. Lancet 359:1616–1617

    Article  CAS  Google Scholar 

  • Hatzidimitriou G, McCann UD, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096–5107

    CAS  PubMed  Google Scholar 

  • Hesse S, Barthel H, Hermann W, Murai T, Kluge R, Wagner A, Sabri O, Eggers B (2003) Regional serotonin transporter availability and depression are correlated in Wilson’s disease. J Neural Transm 110:923–933

    Article  CAS  PubMed  Google Scholar 

  • Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T, Tokudome S (2002) Cross-cultural validation of the Beck Depression Inventory-II in Japan. Psychiatry Res 110:291–299

    Article  PubMed  Google Scholar 

  • Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR (1992) Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse 18:331–341

    CAS  PubMed  Google Scholar 

  • Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL (1993) SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 13:295–309

    PubMed  Google Scholar 

  • Lieb R, Schuetz CG, Pfister H, von Sydow K, Wittchen H (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68:195–207

    Article  PubMed  Google Scholar 

  • Liechti ME, Gamma A, Vollenweider FX (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology 154:161–168

    CAS  PubMed  Google Scholar 

  • MacInnes N, Handley SL, Harding GF (2001) Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. J Psychopharmacol 15:181–186

    CAS  PubMed  Google Scholar 

  • Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS (1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44:1090–1098

    Article  CAS  PubMed  Google Scholar 

  • McCann UD, Eligulashvili V, Ricaurte GA (2000) (±)3,4-Methylenedioxymethamphetamine (“ecstasy”)-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology 42:11–16

    CAS  Google Scholar 

  • McGuire PK, Cope H, Fahy TA (1994) Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine (“ecstasy”). Br J Psychiatry 165:391–395

    CAS  PubMed  Google Scholar 

  • Morgan MJ (1998) Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252–264

    Article  CAS  PubMed  Google Scholar 

  • Morgan MJ, McFie L, Fleetwood H, Robinson JA (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 159:294–303

    CAS  PubMed  Google Scholar 

  • Nelson HE (1991) The revised national adult reading test manual. NFER-Nelson. Windsor, UK

  • Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139:261–268

    Article  CAS  PubMed  Google Scholar 

  • Parrott AC, Sisk E, Turner JJ (2000) Psychobiological problems in heavy “ecstasy” (MDMA) polydrug users. Drug Alcohol Depend 60:105–110

    CAS  PubMed  Google Scholar 

  • Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T (2000) Imaging serotonin and dopamine transporters with 123I-β-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med 41:36–44

    CAS  PubMed  Google Scholar 

  • Reneman L, Booij J, Schmand B, van den Brink W, Gunning B (2000) Memory disturbances in “ecstasy” users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148:322–324

    CAS  PubMed  Google Scholar 

  • Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J (2001a) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”): preliminary findings. Arch Gen Psychiatry 58:901–906

    CAS  PubMed  Google Scholar 

  • Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W (2001b) Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358:1864–1869

    CAS  PubMed  Google Scholar 

  • Reneman L, Booij J, Habraken JBA, de Bruin K, Hatzidimitiou G, den Heeten GJ, Ricaurte GA (2002) Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. Synapse 46:199–205

    Article  CAS  PubMed  Google Scholar 

  • Ricaurte GA, Yuan J, McCann UD (2000) (±)3,4-Methylenedioxymethamphetamine (“ecstasy”)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5–10

    CAS  PubMed  Google Scholar 

  • Scheffel U, Dannals RF, Cline EJ, Ricaurte GA, Carroll FI, Abraham P, Lewin AH, Kuhar MJ (1992) [123/125I]RTI-55, an in vivo label for the serotonin transporter. Synapse 11:134–139

    CAS  PubMed  Google Scholar 

  • Semple DM, Ebmeier KP, Glabus MF, O’Carroll RE, Johnstone EC (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (“ecstasy”) users. Br J Psychiatry 175:63–69

    CAS  PubMed  Google Scholar 

  • Steele TD, McCann UD, Ricaurte GA (1994) 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans. Addiction 89:539–551

    CAS  PubMed  Google Scholar 

  • Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167:85–96

    CAS  PubMed  Google Scholar 

  • Verbaten MN (2003) Specific memory deficits in ecstasy users? The results of a meta-analysis. Hum Psychopharmacol 18:281–290

    Article  PubMed  Google Scholar 

  • Verheyden SL, Hadfield J, Calin T, Curran HV (2002) Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, “ecstasy”) on mood: evidence of gender differences. Psychopharmacology 161:23–31

    Article  CAS  PubMed  Google Scholar 

  • Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJ, de Bruin D, Van de Wijngaart G, Van Gerven JM, Cohen AF (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196–202

    CAS  PubMed  Google Scholar 

  • Vollenweider FX, Gamma A, Liechti M, Huber T (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology 19:241–251

    Article  CAS  PubMed  Google Scholar 

  • Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, Tauscher J, Hilger E, Stastny J, Brücke T, Kasper S (2000) [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 47:482–489

    Article  CAS  PubMed  Google Scholar 

  • World Health Organization (1992) Composite international diagnostic interview. WHO, Geneva

Download references

Author information

Authors and Affiliations

  1. Department of Radiology G1-229, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

    Maartje M. L. de Win, Liesbeth Reneman & Gerard J. den Heeten

  2. Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Johannes B. Reitsma

  3. Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Jan Booij

  4. Amsterdam Institute for Addiction Research and Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Wim van den Brink

Authors
  1. Maartje M. L. de Win
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liesbeth Reneman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Johannes B. Reitsma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gerard J. den Heeten
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jan Booij
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wim van den Brink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maartje M. L. de Win.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Win, M.M.L., Reneman, L., Reitsma, J.B. et al. Mood disorders and serotonin transporter density in ecstasy users—the influence of long-term abstention, dose, and gender. Psychopharmacology 173, 376–382 (2004). https://doi.org/10.1007/s00213-003-1723-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1723-4

Keywords

Search

Navigation